Finally, omalizumab can enhance the antiviral response in patients with allergic asthma, particularly those with high serum IgE levels who are more susceptible to viral-induced exacerbations, especially from respiratory viruses like Rhinovirus and Influenza virus (10, 11). This evidence concerns the gene IGHE and allergic asthma.